chr5-1420686-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001044.5(SLC6A3):​c.810C>T​(p.Ala270Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 1,613,388 control chromosomes in the GnomAD database, including 2,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A270A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.073 ( 1319 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 1257 hom. )

Consequence

SLC6A3
NM_001044.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.44

Publications

8 publications found
Variant links:
Genes affected
SLC6A3 (HGNC:11049): (solute carrier family 6 member 3) This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009]
SLC6A3 Gene-Disease associations (from GenCC):
  • classic dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • SLC6A3-related dopamine transporter deficiency syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • parkinsonism-dystonia, infantile
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 5-1420686-G-A is Benign according to our data. Variant chr5-1420686-G-A is described in ClinVar as Benign. ClinVar VariationId is 470642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.247 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC6A3NM_001044.5 linkc.810C>T p.Ala270Ala synonymous_variant Exon 6 of 15 ENST00000270349.12 NP_001035.1 Q01959

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC6A3ENST00000270349.12 linkc.810C>T p.Ala270Ala synonymous_variant Exon 6 of 15 1 NM_001044.5 ENSP00000270349.9 Q01959
SLC6A3ENST00000713697.1 linkn.810C>T non_coding_transcript_exon_variant Exon 6 of 11 ENSP00000519001.1
SLC6A3ENST00000713696.1 linkc.792+1190C>T intron_variant Intron 5 of 14 ENSP00000519000.1

Frequencies

GnomAD3 genomes
AF:
0.0725
AC:
11038
AN:
152180
Hom.:
1321
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.252
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0265
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00518
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.000999
Gnomad OTH
AF:
0.0463
GnomAD2 exomes
AF:
0.0199
AC:
4979
AN:
250576
AF XY:
0.0146
show subpopulations
Gnomad AFR exome
AF:
0.259
Gnomad AMR exome
AF:
0.0130
Gnomad ASJ exome
AF:
0.00110
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000814
Gnomad OTH exome
AF:
0.00948
GnomAD4 exome
AF:
0.00791
AC:
11560
AN:
1461090
Hom.:
1257
Cov.:
33
AF XY:
0.00697
AC XY:
5066
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.261
AC:
8733
AN:
33464
American (AMR)
AF:
0.0146
AC:
652
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00544
AC:
469
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52838
Middle Eastern (MID)
AF:
0.0136
AC:
78
AN:
5726
European-Non Finnish (NFE)
AF:
0.000536
AC:
596
AN:
1111886
Other (OTH)
AF:
0.0169
AC:
1020
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
582
1164
1745
2327
2909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
258
516
774
1032
1290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0725
AC:
11049
AN:
152298
Hom.:
1319
Cov.:
33
AF XY:
0.0698
AC XY:
5200
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.251
AC:
10441
AN:
41526
American (AMR)
AF:
0.0265
AC:
405
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00518
AC:
25
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.00100
AC:
68
AN:
68032
Other (OTH)
AF:
0.0458
AC:
97
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
435
869
1304
1738
2173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0261
Hom.:
763
Bravo
AF:
0.0830
Asia WGS
AF:
0.0120
AC:
42
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00113

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Parkinsonism-dystonia, infantile Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
11
DANN
Benign
0.75
PhyloP100
2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6348; hg19: chr5-1420801; API